The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis

Author:

Qu X. Melody,Velker Vikram M.,Leung Eric,Kwon Janice S.,Elshaikh Mohamed A.,Kong Iwa,Logie Natalie A.,Mendez Lucas C.,van der Putten Louis J.,Donovan Elysia K.,Munkarah Adnan R.,Wiebe Ericka M.,Parra-Herran Carlos,Warner Andrew,Louie Alexander V.,D'Souza David P.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference36 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers;Hamilton;Br. J. Cancer,2006

3. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics. Cancer of the Corpus Uteri;Ries,2007

4. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review;Boruta;Gynecol. Oncol.,2009

5. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?;Kwon;Int. J. Gynecol. Cancer,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3